nonalcoholic%20fatty%20liver%20disease
NONALCOHOLIC FATTY LIVER DISEASE

Nonalcoholic fatty liver disease is having excessive hepatic fat (in the form of triglycerides) accumulation not due to excessive alcohol consumption or other secondary causes.

It is considered as a hepatic manifestation of metabolic syndrome.

Progression of nonalcoholic fatty liver disease is variable.

Follow Up

  • Patient’s follow-up schedule may vary depending on local protocol, patient’s response and risk factors
  • After 6 months, evaluate weight loss, exercise, diet and lifestyle changes
  • Twice annually the following tests should be done:
    • Blood test with platelet count
    • Liver biochemical tests
    • Prothrombin time
  • Depending on risk factors present, do the following every 1-2 years:
    • Screen for cardiovascular risk
    • Liver biopsy
  • Imaging tests can only be done when indicated
  • Screen patients with NASH cirrhosis for gastroesophageal varices 
  • Screen NAFLD patients with suspected cirrhosis for hepatocellular carcinoma
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 14 Aug 2018
A new study reinforces the gut-brain connection in Alzheimer’s disease (AD), untangling the complex interplay between gut and brain health that could potentially lead to new therapies targeted at manipulating the gut microbiome to treat AD.
Roshini Claire Anthony, 6 days ago

Reducing the dose of regorafenib did little to affect the overall tolerability of the drug in patients with metastatic colorectal cancer (mCRC), according to the phase II REARRANGE* trial presented at ESMO GI 2019.